SIG on Pharmacy Practice Research

Chair: Prof. Shalom (Charlie) Benrimoj (Australia)
Vice-Chairs: Prof. Martin Schulz (Germany) and Prof. Ross T. Tsuyuki (Canada)
Liaison with Board of Pharmaceutical Practice: Prof. Tim Chen (Australia)

Internationally, the scope of pharmacy practice research has expanded over the past 50 years to encompass areas such as the clinical, behavioural, economic and humanistic implications of the practice of pharmacy, heath care systems, medicines use and patient care.  The drive for the expanded role of the pharmacist, in most practice environments, has been stimulated by professional evolution, professional organisations and research.

At an international level this special interest group (SIG) provides a unique opportunity to develop an international strategy for pharmacy practice research to underpin international positions and policy. The Special Interest Group on Pharmacy Practice Research will allow exchange of pharmacy practice research between senior researchers, early career researchers, postdoctoral fellows, pharmacist practitioners and PhD or MSc students in order to produce high quality evidence at an international level. The SIG will allow a wider dissemination and exposure of high quality pharmacy practice research to all stakeholders, as well as encourage and foster greater communication, discussion, networking and collaboration at an international level for the advancement of best practice research.

 

The objectives of the pharmacy practice research SIG are to:

  1. Cultivate an international forum for the ever widening scope of pharmacy practice research
  2. Create a forum for the dissemination of quality, international pharmacy practice research for all stakeholders.
  3. Develop a policy statement on current and future pharmacy practice research, including a global definition for Pharmacy Practice Research.
  4. Contribute to the teaching and learning of pharmacy practice research by providing practitioners and students of pharmacy and pharmaceutical sciences with greater access to the latest evidence-based practice and highest quality international pharmacy practice research.
  5. Stimulate communication, discussion, networking and collaboration between international pharmacy practice stakeholders, including pharmacists and pharmaceutical scientists for the advancement of best practice.
  6. Increase pharmacy practice contributions to global health through the provision of greater access to the latest high quality international pharmacy practice research.

 

For more information on this SIG, please contact Prof. Benrimoj at pharmacypracticeresearch@fip.org.